Delivery Order SPE2DB20D3103-SPE2DB25FM6T2

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Brimonidine Tartrate 0.15% ophthalmic drops. The $1,957.02 firm fixed-price contract has an ultimate completion date of April 10, 2024. AmerisourceBergen is a for-profit organization that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,008.76 and is for the procurement of BRIMONIDINE TARTRATE 0.15% DRP 5ML, a specialized eye drop medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,031.10 firm fixed price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% 5ml, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to deliver a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract has a ceiling value of $6,782.94 and a completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.25 delivery order is for 4559068177 - ALPHAGAN P 0.15% EYE DROPS 5ML, with a completion date of November 14, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This contract award, with ID SPE2DB20D3103|SPE2DB23FM6W3, is for the delivery of Brimonidine Tartrate 0.15% ophthalmic drops in 15ml bottles to the Defense Logistics Agency (DLA). The $6,753.71 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on March 7, 2023 with a completion date of March 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,594.28 firm fixed-price delivery order is for the provision of 4565243277 - Dorzolamide-Timolol eye drops, 10 mL. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of ALPHAGAN P 0.15% eye drops in 5 milliliter bottles. The $3,016.75 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on October 31, 2022 with a completion date of November 1, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is valued at $6,135.81. The contract was awarded by the Defense Logistics Agency (DLA) and includes the delivery of 4566861414 ! VEVYE 0.1% EYE DROP 2ML medical products. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 8, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM6T2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.36 Firm Fixed Price Delivery Order is for the supply of Brimonidine Tartrate 0.15% eye drops, with a completion date of February 12, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/13/25, 9:48 AM